Metabolic risk factors of ovarian cancer: a review

Neda Khanlarkhani, Elham Azizi, Fardin Amidi, Mahshad Khodarahmian, Ensieh Salehi, Azar Pazhohan, Bagher Farhood, Keywan Mortezae, Nasser Hashemi Goradel, Maryam Shabani NashtaeiJBRA 2021 · DOI

TL;DR

This review synthesizes current research on the link between metabolic disorders like obesity and diabetes mellitus (DM) and ovarian cancer. It highlights that these conditions are associated with increased incidence and poorer survival rates, and explores the underlying biological mechanisms, suggesting potential avenues for intervention.

What Problem Does This Paper Address?

Ovarian cancer remains a significant cause of mortality among gynecological cancers, often diagnosed at advanced stages. While various risk factors are known, the role of metabolic abnormalities, specifically obesity and type 2 diabetes mellitus (DM), in both the incidence and survival of ovarian cancer is a growing area of concern. Despite existing studies, there's a need for a comprehensive overview that consolidates the evidence and elucidates the biological pathways connecting these metabolic conditions to ovarian cancer. This paper aims to bridge this gap by reviewing the literature on the association between obesity, DM, and ovarian cancer, focusing on incidence, mortality, and the underlying mechanisms.

Methods

This paper is a comprehensive review of existing scientific literature. The authors systematically searched and analyzed published studies, including systematic reviews and meta-analyses, to synthesize the current understanding of the relationship between metabolic risk factors (obesity and DM) and ovarian cancer. The review focuses on identifying correlations, potential causal links, and biological mechanisms.

Datasets

Not discussed in the paper. This is a review article, not an empirical study that collected or analyzed new data.

Key Insights and Ideas

  • Obesity as a Double-Edged Sword: Obesity is not only linked to a higher incidence of ovarian cancer but also to poorer survival outcomes. This suggests it plays a role in both the development and progression of the disease.
  • Diabetes Mellitus's Complex Role: While the direct etiological link between DM and ovarian cancer is still being investigated, there's substantial biological evidence pointing towards poorer outcomes and shorter survival for diabetic women diagnosed with ovarian cancer.
  • Adipose Tissue: More Than Just Storage: Adipose tissue, particularly in the context of obesity, acts as an active endocrine organ. It secretes various factors (adipokines) that can promote inflammation, alter immune responses, and contribute to tumor growth and metastasis.
  • Hormonal Imbalances: Metabolic derangements can lead to significant changes in sex hormones, such as estrogen and androgens, which are known to influence ovarian cancer development and progression.
  • Inflammation as a Common Thread: Both obesity and DM are characterized by chronic inflammation, which plays a crucial role in promoting cancer cell proliferation, invasion, and evasion of the immune system.
  • Metformin's Potential: The paper briefly mentions that metformin, a common diabetes medication, has shown potential in improving cancer outcomes, possibly by inhibiting pathways involved in tumor progression.
  • The Need for Subtype-Specific Research: The authors emphasize that more research is needed to understand how metabolic abnormalities affect specific subtypes of ovarian cancer, as their roles might differ.

Key Results

  • Several systematic reviews and meta-analyses indicate that obesity is associated with a higher incidence of ovarian cancer and poorer survival rates.
  • While the direct link between DM and ovarian cancer incidence is less clear, sufficient biological evidence suggests poorer outcomes and shorter survival in diabetic women with ovarian cancer.
  • The review details various pathological factors contributing to ovarian cancer risk, development, and survival, including altered adipokine expression (e.g., leptin, IL-6), increased growth factors, sex hormone imbalances, insulin resistance, hyperinsulinemia, and chronic inflammation.
  • The paper highlights that obesity and DM are modifiable risk factors, suggesting they can be targeted for interventions to prevent ovarian cancer and improve patient outcomes.

Limitations and Future Work

  • Inconsistent Findings: The authors acknowledge that there are inconsistent findings in the literature regarding the precise relationship between obesity and ovarian cancer risk, necessitating further investigation.
  • Etiological Link of DM: The detailed etiological link between DM and ovarian cancer is still not fully understood, requiring more studies to clarify this relationship.
  • Subtype-Specific Associations: There is a lack of sufficient studies that estimate the subtype-specific associations between metabolic abnormalities and ovarian cancer. The authors call for supplementary studies to address this gap.
  • Need for Well-Designed Studies: While many studies suggest an association between obesity and ovarian cancer survival, some have not found this link. The authors stress the need for more well-designed studies to elucidate the various effects of obesity on survival rates.
  • Intervention Strategies: The paper suggests that targeting obesity and DM as modifiable risk factors could be a key strategy for preventing ovarian cancer and improving its outcomes, implying a need for further research into effective intervention strategies.

Summary updated

Abstract

Ovarian cancer continues to be the leading cause of death from gynecological cancers. Despite inconsistent results, patients with metabolic abnormalities, including obesity and diabetes mellitus (DM), have poorer outcomes, showing a correlation with ovarian cancer incidence and ovarian cancer survival. Since ovarian cancer is the most common cancer in women, and considering the increasing prevalence of obesity and DM, this paper reviews the literature regarding the relationship between the aforementioned metabolic derangements and ovarian cancer, with a focus on ovarian cancer incidence, mortality, and likely mechanisms behind them. Several systematic reviews and meta-analyses have shown that obesity is associated with a higher incidence and poorer survival in ovarian cancer. Although more studies are required to investigate the etiological relation of DM and ovarian cancer, sufficient biological evidence indicates poorer outcomes and shorter survival in DM women with ovarian cancer. A variety of pathologic factors may contribute to ovarian cancer risk, development, and survival, including altered adipokine expression, increased levels of circulating growth factors, altered levels of sex hormones, insulin resistance, hyperinsulinemia, and chronic inflammation. Thus, obesity and DM, as changeable risk factors, can be targeted for intervention to prevent ovarian cancer and improve its outcomes.
BibTeX
@inproceedings{khanlarkhani2021metabolic,
  author = {Neda Khanlarkhani and Elham Azizi and Fardin Amidi and Mahshad Khodarahmian and Ensieh Salehi and Azar Pazhohan and Bagher Farhood and Keywan Mortezae and Nasser Hashemi Goradel and Maryam Shabani Nashtaei},
  title = {{Metabolic risk factors of ovarian cancer: a review}},
  booktitle = {JBRA},
  year = {2021},
  doi = {10.5935/1518-0557.20210067},
}
Figure